Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 14 of 27
 |<   <<   <  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  >   >>   >| 

Scientific Advancements
Monday, August 30, 2021   (0 Comments - view/add)
New Research Shows that Wounds heal faster with Gladiator Therapeutics Patented SemiCera® Technology »
New Research Shows that Wounds heal faster with Gladiator Therapeutics Patented SemiCera® Technology WHITEHALL, Pa....
Monday, August 30, 2021   (0 Comments - view/add)
OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic »
OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients...
Wednesday, August 25, 2021   (0 Comments - view/add)
Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administrati »
Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Va...
Wednesday, August 25, 2021   (0 Comments - view/add)
AIM ImmunoTech Announces Filing of Provisional Patent Application for Use of Ampligen as Both an Int »
AIM ImmunoTech Announces Filing of Provisional Patent Application for Use of Ampligen as Both an Intranasal and an IV...
Monday, August 23, 2021   (0 Comments - view/add)
FDA Approves First COVID-19 Vaccine »
FDA Approves First COVID-19 Vaccine Approval Signifies Key Achievement for Public Health...
Monday, August 23, 2021   (0 Comments - view/add)
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years »
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY ® Receives Full U.S. FDA Approval for Individuals 16 Years and Older C...
Wednesday, August 18, 2021   (0 Comments - view/add)
Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots »
Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots Med...
Wednesday, August 18, 2021   (0 Comments - view/add)
AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cys »
AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patie...
Tuesday, August 17, 2021   (0 Comments - view/add)
HCW Biologics’ Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffol »
HCW Biologics’ Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Prot...
Monday, August 16, 2021   (0 Comments - view/add)
Enzymedica Launches Gut Motility™, a New Artichoke and Ginger-Based Formula That Uniquely Offers Sup »
Enzymedica Launches Gut Motility™, a New Artichoke and Ginger-Based Formula That Uniquely Offers Support for Healthier G...
Thursday, August 12, 2021   (0 Comments - view/add)
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical T »
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamid...
Thursday, August 12, 2021   (0 Comments - view/add)
Vivex Biologics, Inc. Launches CYGNUS® Matrix Disks »
Vivex Biologics, Inc. Launches CYGNUS® Matrix Disks Amniotic tissue allografts can be used as a barrier in numerous c...
Wednesday, August 11, 2021   (0 Comments - view/add)
Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution »
Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution...
Tuesday, August 10, 2021   (0 Comments - view/add)
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Ni »
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the...
Monday, August 9, 2021   (0 Comments - view/add)
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA »
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB® ADMA Expands...
Friday, July 30, 2021   (0 Comments - view/add)
FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab) »
FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)...
Friday, July 30, 2021   (0 Comments - view/add)
Cyclo Therapeutics Announces New Positive Safety and Efficacy Data from Ongoing Phase 1 Open-Label E »
Cyclo Therapeutics Announces New Positive Safety and Efficacy Data from Ongoing Phase 1 Open-Label Extension Study of Trap...
Monday, July 26, 2021   (0 Comments - view/add)
Evren Technologies receives FDA Breakthrough Device Designation for the Phoenix® - Revolutionary Tra »
Evren Technologies receives FDA Breakthrough Device Designation for the Phoenix® - Revolutionary Transcutaneous Auricula...
Wednesday, July 21, 2021   (0 Comments - view/add)
KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and dex »
KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsu...
Thursday, July 15, 2021   (0 Comments - view/add)
AdventHealth Ocala Using Innovative Technology for Lung Cancer Diagnosis »
AdventHealth Ocala Using Innovative Technology for Lung Cancer Diagnosis The hospital is the first in Marion County to...
Tuesday, July 13, 2021   (0 Comments - view/add)
Cell Science Systems Reports Newly Discovered Cause of Delayed Food Allergies (Sensitivities) »
Cell Science Systems Reports Newly Discovered Cause of Delayed Food Allergies (Sensitivities)...
Friday, July 9, 2021   (0 Comments - view/add)
AIM ImmunoTech Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an Intranasal A »
AIM ImmunoTech Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an Intranasal Antiviral Prophylac...
Tuesday, July 6, 2021   (0 Comments - view/add)
Longeveron Announces First Patient Treated in Phase 2b Hypoplastic Left Heart Syndrome (HLHS) Clinic »
Longeveron Announces First Patient Treated in Phase 2b Hypoplastic Left Heart Syndrome (HLHS) Clinical Study...
Thursday, June 24, 2021   (0 Comments - view/add)
AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic »
AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patie...
Thursday, June 24, 2021   (0 Comments - view/add)
Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer’s Disease Trial Accepted for »
Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer’s Disease Trial Accepted for Developing Topics...
Wednesday, June 23, 2021   (0 Comments - view/add)
Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Nonalcoholic Fatty Liver Disease »
Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Nonalcoholic Fatty Liver Disease...
Monday, June 21, 2021   (0 Comments - view/add)
AIM ImmunoTech Completes All Treatments in Phase 1 Human Safety Study of Intranasal Administration o »
AIM ImmunoTech Completes All Treatments in Phase 1 Human Safety Study of Intranasal Administration of Ampligen...
Thursday, June 17, 2021   (0 Comments - view/add)
Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating »
Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol ® Cyclo™ in...
Monday, June 14, 2021   (0 Comments - view/add)
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and »
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in...
Friday, June 11, 2021   (0 Comments - view/add)
Stuart Therapeutics Announces Start of Patient Enrollment in its Phase 2 Clinical Trial of ST-100 fo »
Stuart Therapeutics Announces Start of Patient Enrollment in its Phase 2 Clinical Trial of ST-100 for Dry Eye Disease...
Tuesday, June 8, 2021   (0 Comments - view/add)
Medtronic nets U.S. approval for brain activity-sensing Parkinson's stimulation implant »
www.fiercebiotech.com /medtech/medtronic-nets-u-s-approval-for-brain-activity-sensing-parkinson-s-stimulation-implant...
Monday, June 7, 2021   (0 Comments - view/add)
AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of C »
AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointe...
Wednesday, May 26, 2021   (0 Comments - view/add)
KemPharm, Inc. Announces Orange Book Listing for Six Patents Covering Serdexmethylphenidate (SDX) an »
KemPharm, Inc. Announces Orange Book Listing for Six Patents Covering Serdexmethylphenidate (SDX) and Confirmation of NCE...
Tuesday, May 25, 2021   (0 Comments - view/add)
TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Applicat »
TherapeuticsMD Announces Submission of Low Dose BIJUVA ® 0.5 mg/100 mg Supplemental New Drug Application to FDA...
Thursday, May 20, 2021   (0 Comments - view/add)
Tampa General Hospital and USF Health Team Offer Minimally Invasive Alternative for Surgical Treatme »
Tampa General Hospital and USF Health Team Offer Minimally Invasive Alternative for Surgical Treatment of Uterine Fib...

Displaying page 14 of 27
 |<   <<   <  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  >   >>   >| 

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)